06:31 AM EDT, 04/18/2024 (MT Newswires) -- Elevance Health ( ELV ) reported Q1 adjusted earnings Thursday of $10.64 per diluted share, up from $9.46 a year earlier.

Analysts polled by Capital IQ expected $10.53.

Revenue for the quarter ended March 31 was $42.58 billion, up from $42.17 billion a year earlier.

Analysts surveyed by Capital IQ expected $42.44 billion.

The company said it expects 2024 adjusted diluted EPS to be greater than $37.20, higher than its previous outlook of greater than $37.10. Analysts polled by Capital IQ are expecting $37.15.